These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37944778)

  • 1. Use of Anticoagulation for Thromboembolic Prophylaxis in Patients With Atrial High-Rate Episodes on Device Monitoring: A Narrative Review.
    Leung ANW; Bhat A
    Am J Cardiol; 2024 Jan; 211():183-190. PubMed ID: 37944778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are atrial high rate episodes (AHREs) a precursor to atrial fibrillation?
    Khan AA; Boriani G; Lip GYH
    Clin Res Cardiol; 2020 Apr; 109(4):409-416. PubMed ID: 31522249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Impact of Oral Anticoagulation in Patients with Atrial High-rate Episodes.
    Marinheiro R; Parreira L; Amador P; Lopes C; Fernandes A; Mesquita D; Farinha J; Fonseca M; Duarte T; Caria R
    J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):971-979. PubMed ID: 30642667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When is Device-Detected Atrial Fibrillation Actionable?
    Wasserlauf J; Passman RS
    Card Electrophysiol Clin; 2018 Mar; 10(1):75-85. PubMed ID: 29428144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silent atrial fibrillation as a stroke risk factor and anticoagulation indication.
    Glotzer TV; Ziegler PD
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S14-23. PubMed ID: 23790594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and Design of the Evaluation of Oral Anticoagulation for Reduction of Thrombo-embolism in Chinese Patients with Device-Detected Subclinical Atrial Fibrillation (ART-CAF) Trial: an Open-Label Registry-Based Clinical Trial.
    Yang Y; Xu F; Tong J; Cai L; Jiang W; Sheng X; Pan Y; Jiang J; Zhang J; Jiang D; Zhao L; Fu G
    Cardiovasc Drugs Ther; 2018 Aug; 32(4):389-396. PubMed ID: 30027309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial high-rate episodes: prevalence, stroke risk, implications for management, and clinical gaps in evidence.
    Bertaglia E; Blank B; Blomström-Lundqvist C; Brandes A; Cabanelas N; Dan GA; Dichtl W; Goette A; de Groot JR; Lubinski A; Marijon E; Merkely B; Mont L; Piorkowski C; Sarkozy A; Sulke N; Vardas P; Velchev V; Wichterle D; Kirchhof P
    Europace; 2019 Oct; 21(10):1459-1467. PubMed ID: 31377792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying Time in Atrial Fibrillation and the Need for Anticoagulation.
    Miyazawa K; Pastori D; Lip GYH
    Prog Cardiovasc Dis; 2018; 60(4-5):537-541. PubMed ID: 29289494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
    Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
    BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection of atrial high rate episodes predicts atrial fibrillation and thromboembolic events in patients with cardiac resynchronization therapy.
    Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Nielsen JC
    Heart Rhythm; 2015 Dec; 12(12):2368-75. PubMed ID: 26164377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of atrial high-rate episodes detected by cardiac implanted electronic devices.
    Freedman B; Boriani G; Glotzer TV; Healey JS; Kirchhof P; Potpara TS
    Nat Rev Cardiol; 2017 Dec; 14(12):701-714. PubMed ID: 28682320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What to do with device-detected atrial high-rate episodes: Summary of the evidences.
    Özge Mert G; Kepez A; Uğur Mert K; Görenek B
    Pacing Clin Electrophysiol; 2022 Feb; 45(2):250-261. PubMed ID: 34927268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical classification and the subclinical atrial fibrillation challenge: a position paper of the European Cardiac Arrhythmia Society.
    Lévy S; Santini L; Cappato R; Steinbeck G; Capucci A; Saksena S
    J Interv Card Electrophysiol; 2020 Dec; 59(3):495-507. PubMed ID: 33048302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How should I treat patients with subclinical atrial fibrillation and atrial high-rate episodes? Current evidence and clinical importance.
    Kreimer F; Mügge A; Gotzmann M
    Clin Res Cardiol; 2022 Sep; 111(9):994-1009. PubMed ID: 35292844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Device-detected atrial fibrillation: what to do with asymptomatic patients?
    Chen-Scarabelli C; Scarabelli TM; Ellenbogen KA; Halperin JL
    J Am Coll Cardiol; 2015 Jan; 65(3):281-94. PubMed ID: 25614426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial High-Rate Episodes in Patients with Devices Without a History of Atrial Fibrillation: a Systematic Review and Meta-analysis.
    Doundoulakis I; Gavriilaki M; Tsiachris D; Arsenos P; Antoniou CK; Dimou S; Soulaidopoulos S; Farmakis I; Akrivos E; Stoiloudis P; Notas K; Kimiskidis VK; Giannakoulas G; Paraskevaidis S; Gatzoulis KA; Tsioufis K
    Cardiovasc Drugs Ther; 2022 Oct; 36(5):951-958. PubMed ID: 34089429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of device-detected atrial high-rate episodes.
    Tomson TT; Passman R
    Card Electrophysiol Clin; 2015 Sep; 7(3):515-25. PubMed ID: 26304531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cardiac electronic implantable device in the stratification and management of embolic risk of silent atrial fibrillation: are all atrial fibrillations created equal?
    Di Cori A; Lilli A; Zucchelli G; Zaca V
    Expert Rev Cardiovasc Ther; 2018 Mar; 16(3):175-181. PubMed ID: 29431527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial high-rate episodes and stroke prevention.
    Camm AJ; Simantirakis E; Goette A; Lip GY; Vardas P; Calvert M; Chlouverakis G; Diener HC; Kirchhof P
    Europace; 2017 Feb; 19(2):169-179. PubMed ID: 28172715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and outcomes of atrial fibrillation patients with or without specific symptoms: results from the PREFER in AF registry.
    Bakhai A; Darius H; De Caterina R; Smart A; Le Heuzey JY; Schilling RJ; Zamorano JL; Shah M; Bramlage P; Kirchhof P
    Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):299-305. PubMed ID: 29474715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.